Trial Details
RECRUITINGBasic Information
| Clinical ID | c14 |
|---|---|
| Identifier | NCT07421011 |
| Trial Title | Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome|Gallstone Disease|GERD|Biliary Dyskinesia|Postcholecystectomy Syndrome |
| Interventions | DRUG: Trimedat® |
Participant Information
| Sponsor | Valenta Pharm JSC |
|---|---|
| City | Saint Petersburg |
| Country/Region | Russia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-11-06 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2026-12-31 |